Naturhouse Health (XMAD:NTH) 5-Year Yield-on-Cost %: 9.92 (As of Jul. 12, 2026) — Near Median


XMAD:NTH Naturhouse Health SA XMAD:NTH
81 GF Score
Price €2.52
GF Value €1.62
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Naturhouse Health 5-Year Yield-on-Cost %?

Naturhouse Health XMAD:NTH -1.18% 81 5-Year Yield-on-Cost % is 9.92 as of Jul. 12, 2026, which is 8% below its 10-year median of 10.74. GuruFocus rates XMAD:NTH with a GF Score™ of 81/100 and a GF Value™ of €1.62 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,173 Consumer Packaged Goods companies, Naturhouse Health ranks better than 86.62% on this metric.

Naturhouse Health's yield on cost for the quarter that ended in Dec. 2025 was 9.92.


The historical rank and industry rank for Naturhouse Health's 5-Year Yield-on-Cost % or its related term are showing as below:

XMAD:NTH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.91   Med: 10.74   Max: 23.46
Current: 9.92


During the past 13 years, Naturhouse Health's highest Yield on Cost was 23.46. The lowest was 0.91. And the median was 10.74.


XMAD:NTH's 5-Year Yield-on-Cost % is ranked better than
86.62% of 1173 companies
in the Consumer Packaged Goods industry
Industry Median: 3.41 vs XMAD:NTH: 9.92

Naturhouse Health  (XMAD:NTH) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Naturhouse Health 5-Year Yield-on-Cost % Related Terms


XMAD:NTH vs KHC, GIS, HRL: 5-Year Yield-on-Cost % Comparison

For the Packaged Foods subindustry, Naturhouse Health's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Naturhouse Health 5-Year Yield-on-Cost % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Naturhouse Health's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Naturhouse Health's 5-Year Yield-on-Cost % falls into.


XMAD:NTH
81GF Score
Naturhouse Health SA XMAD:NTH
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Naturhouse Health 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Naturhouse Health is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 9.92 mean?
Naturhouse Health (XMAD:NTH) has a 5-Year Yield-on-Cost % of 9.92 as of Jul. 12, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Naturhouse Health and its competitors. This is near median its historical median of 10.74. Over the past decade, Naturhouse Health's 5-Year Yield-on-Cost % has ranged from 0.91 to 23.46. According to the industry distribution chart, Naturhouse Health ranks #157 out of 1173 companies in the Consumer Packaged Goods industry, placing it in the top 13.4%.
Is Naturhouse Health's 5-Year Yield-on-Cost % too high?
Naturhouse Health's current 5-Year Yield-on-Cost % of 9.92 is near median its 10-year median of 10.74. Over the past 10 years, this metric has ranged from a low of 0.91 to a high of 23.46. The Consumer Packaged Goods industry median 5-Year Yield-on-Cost % is 3.41. Naturhouse Health's value of 9.92 is 190.9% above this industry median. Based on the distribution chart, Naturhouse Health ranks #157 out of 1173 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Naturhouse Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Naturhouse Health's 5-Year Yield-on-Cost % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Naturhouse Health ranks #157 out of 1173 companies for 5-Year Yield-on-Cost %. This places Naturhouse Health in the top 13% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 3.41. Naturhouse Health's value of 9.92 is 190.9% above this benchmark. Historically, Naturhouse Health's own 5-Year Yield-on-Cost % has ranged from 0.91 to 23.46 over the past decade. While the company's 10-year median is 10.74 vs. the industry median of 3.41, Naturhouse Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Consumer Packaged Goods company?
The median 5-Year Yield-on-Cost % among Consumer Packaged Goods companies is 3.41, based on 1,173 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturhouse Health's current 5-Year Yield-on-Cost % of 9.92 is 190.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Naturhouse Health and its competitors. For the Consumer Packaged Goods industry, the median 5-Year Yield-on-Cost % is 3.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturhouse Health's current 5-Year Yield-on-Cost % is 9.92, which is near median its own 10-year median of 10.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturhouse Health stock overvalued right now?
Based on GuruFocus' analysis, Naturhouse Health (XMAD:NTH) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.62, compared to a current price of €2.52 — trading 55.6% above its estimated fair value. The current 5-Year Yield-on-Cost % is 9.92, which is near median its 10-year median of 10.74 and 190.9% above the Consumer Packaged Goods industry median of 3.41. Naturhouse Health's overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Naturhouse Health (XMAD:NTH), the current 5-Year Yield-on-Cost % is 9.92 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Naturhouse Health (XMAD:NTH) Overvalued in 2026?

Based on GuruFocus' analysis, Naturhouse Health stock appears to be overvalued. The current stock price of €2.52 is trading 55.6% above its estimated GF Value™ of €1.62. GuruFocus considers Naturhouse Health to be Significantly Overvalued.

Key valuation signals for XMAD:NTH:

  • 5-Year Yield-on-Cost %: 9.92 (near median its 10-year median of 10.74)
  • GF Value™: €1.62 vs. price of €2.52 (55.6% above fair value)
  • GF Score™: 81/100 with 6 warning signs
  • Industry Position: 190.9% above the Consumer Packaged Goods median (#157 of 1173)

No single metric tells the full story. See the XMAD:NTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Naturhouse Health Business Description

Other Exchanges 0R9G:UK2NH:Germany
Address Calle Claudio Coello, 91, 4º Planta, Madrid, ESP, 28006
Naturhouse Health SA provides nutrition & weight management products. The activity of the company is the export, wholesale, and retail sales of all kinds of products related to dietetics, herbal remedies, and natural cosmetics, as well as the preparation, promotion, creation, edition, dissemination, sale, and distribution of all kinds of magazines, books, and brochures and the marketing of dietary products, herbal remedies, and natural cosmetics. This activity is mainly carried out through franchisees and its stores. The geographical segments of the company are Spain, France, Italy, Poland, and Other countries.
81GF Score

Get the complete analysis for XMAD:NTH

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.52
Price
€1.62
GF Value